In this study, we investigated the specific inhibitory effect of EGFR TK inhibitor EKB-569 on the regulation of NFκB-dependent survival advantage and elucidated its influence in potentiating radiotherapy for head and neck cancers. The gene discussed is NFKB1; the disease is head and neck cancer.